| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Patterson Martin Edward | President and CEO | 12300 LIBERTY BLVD., ENGLEWOOD | /s/ Brittany A. Uthoff as Attorney-in-Fact for Martin E. Patterson | 14 Jul 2025 | 0001848881 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | LBRDK | Series A Common Stock | 270 | 14 Jul 2025 | Direct | ||||||
| holding | LBRDK | Series A Cumulative Redeemable Preferred Stock | 225 | 14 Jul 2025 | Direct | ||||||
| holding | LBRDK | Series C Common Stock | 2,506 | 14 Jul 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | LBRDK | Restricted Stock Units-LBRDK | 14 Jul 2025 | Series C Common Stock | 771 | Direct | F1, F2 | |||||||
| holding | LBRDK | Stock Option - LBRDK (Right to Buy) | 14 Jul 2025 | Series C Common Stock | 3,191 | $76.45 | Direct | F3 | ||||||
| holding | LBRDK | Stock Option - LBRDK (Right to Buy) | 14 Jul 2025 | Series C Common Stock | 7,595 | $77.68 | Direct | F4 | ||||||
| holding | LBRDK | Stock Option - LBRDK (Right to Buy) | 14 Jul 2025 | Series C Common Stock | 3,541 | $116.90 | Direct | F5 | ||||||
| holding | LBRDK | Stock Option - LBRDK (Right to Buy) | 14 Jul 2025 | Series C Common Stock | 4,364 | $118.43 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | This restricted stock unit award vests in two substantially equal installments on December 9, 2025 and 2026. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. |
| F3 | This option award vests in three substantially equal installments on December 11, 2024, 2025, and 2026. |
| F4 | Represents a retention grant which vested 50% on December 13, 2024 and will vest 25% on December 13, 2025 and 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |
| F5 | This option award is fully exercisable. |